Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for October 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Fascia Lata Can Substitute for Nasal Lining in Reconstruction
WEDNESDAY, Oct. 31 (HealthDay News) -- Fascia lata, which is a thin, pliable, and vascularized tissue, can be effectively used as a substitute for nasal lining in complex total and subtotal nasal reconstruction procedures, according to a case series published online Oct. 29 in the Archives of Facial Plastic Surgery.
U.S. Medicare Spending on Elderly Has Outpaced Canada's
TUESDAY, Oct. 30 (HealthDay News) -- U.S. Medicare spending on the elderly has grown nearly three times faster than its Canadian counterpart, according to a study published online Oct. 29 in the Archives of Internal Medicine.
Genuine Very Large Effects in Trials Rare in Medicine
TUESDAY, Oct. 23 (HealthDay News) -- Large treatment effects are most likely to be found in small studies, with the effect diminishing with additional trials, according to research published in the Oct. 24 issue of the Journal of the American Medical Association.
Return to Work Difficult for Doctors on Sick Leave
THURSDAY, Oct. 18 (HealthDay News) -- Returning to work after a prolonged sick leave for physical or mental health problems, or drug or alcohol problems, is difficult for doctors, who describe self-stigmatization and fear a negative response on their return to work, according to a study published online Oct. 15 in BMJ Open.
Case Series Suggest 'Mother's Kiss' Is Safe, Effective
TUESDAY, Oct. 16 (HealthDay News) -- A technique known as "mother's kiss" is safe and generally effective for removing foreign objects from children's noses, according to a review published online Oct. 15 in CMAJ, the journal of the Canadian Medical Association.
Gene Signature Validated for Oral Cancer Metastases
FRIDAY, Oct. 12 (HealthDay News) -- A multigene signature effectively predicts the presence of lymph node metastases in squamous cell carcinoma of the oral cavity (OSCC) and oropharynx (OPSCC), according to a study published online Oct. 8 in the Journal of Clinical Oncology.
Sphere-Templated Tissue Scaffold Is a Viable Subcutaneous Implant
FRIDAY, Oct. 12 (HealthDay News) -- Compared with high-density porous polyethylene (HDPPE) implant materials, sphere-templated poly (2-hydroxyethyl methacrylate) (poly[HEMA]) tissue scaffold stimulates a minimal inflammatory response; supports cellular ingrowth, collagen formation, and neovascularization; and may induce less scar formation, according to an experimental study published online Oct. 8 in the Archives of Facial Plastic Surgery.
Bitter Taste Linked to Response to Respiratory Infections
WEDNESDAY, Oct. 10 (HealthDay News) -- Bitter taste receptors are connected with the ability to detect and respond to gram-negative bacteria such as Pseudomonas aeruginosa in the upper respiratory tract, according to a study published online Oct. 8 in the Journal of Clinical Investigation.
Dysphagia Not Tied to Post-Anterior Cervical Op Swelling
FRIDAY, Oct. 5 (HealthDay News) -- Although significant soft-tissue swelling can occur after anterior cervical discectomy and fusion (ACDF) procedures, the width of the prevertebral soft-tissue swelling on radiographic analysis does not correlate with the severity of postoperative dysphagia, according to research published in the August issue of The Spine Journal.
Limiting the Problem of Missing Data Urged for Clinical Trials
WEDNESDAY, Oct. 3 (HealthDay News) -- Missing data compromise inferences from clinical trials, and due to the problematic nature of compensation with analysis methods, the importance of avoiding missing data in clinical trials is paramount, according to a special report published in the Oct. 4 issue of the New England Journal of Medicine.
High-Dose Vitamin D Does Not Prevent or Treat Colds
TUESDAY, Oct. 2 (HealthDay News) -- High monthly doses of vitamin D do not reduce the incidence or severity of upper respiratory tract infections (URTIs), according to a study published in the Oct. 3 issue of the Journal of the American Medical Association.
Common Herbicide Linked to Rare Birth Defect
TUESDAY, Oct. 2 (HealthDay News) -- Maternal exposure to a common herbicide, atrazine, is associated with a nearly two-fold higher risk of having offspring with a rare birth defect of the nasal cavity, according to a study published online Sept. 28 in The Journal of Pediatrics.
Patients Benefit From Access to Physician Notes
MONDAY, Oct. 1 (HealthDay News) -- Patients report clinically relevant benefits and minimal concerns, while doctors do not experience negative consequences, from allowing patient access to visit notes, according to a study published in the Oct. 1 issue of the Annals of Internal Medicine.
Copyright © 2012 ScoutNews, LLC. All rights reserved.
|Previous: October 2012 Briefing - Emergency Medicine||Next: October 2012 Briefing - Nephrology|
Reader comments on this article are listed below. Review our comments policy.